# Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome

> **NCT02295202** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 100 (actual)

## Conditions studied

- Sleep Apnea
- Metabolic Syndrome

## Interventions

- **DEVICE:** CPAP (REMstar System One Plus - Philips Medical Systems)
- **DEVICE:** Nasal strips

## Key facts

- **NCT ID:** NCT02295202
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2019-04
- **Final completion:** 2019-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02295202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02295202, "Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02295202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*